Pfizer Inc. (PFE) has 20 已知的内部人和机构持有人记录. 最大持有人为 BOURLA ALBERT 持有 759,049 股. 其他重要持有人包括 Dolsten Mikael 和 Baum Andrew.
过去12个月，内部人进行了 82 笔交易，涉及 PFE 股票 — 69 笔买入 (价值为 $64.79M) 和 0 笔卖出 (价值为 RSU 奖励). 内部人买入超过卖出，可能表明对公司前景有信心.
PFE 內部人持股
最大持股人
BOURLA ALBERT
759,049 股
主要內部人持股
| # |
姓名 |
职位 |
持股数量 |
最近申报日期 |
相对规模 |
| 1 |
Bourla Albert |
Chairman & CEO |
759,049 |
2026-04-01 |
|
| 2 |
Dolsten Mikael |
President R&d |
321,729 |
2024-02-29 |
|
| 3 |
Baum Andrew |
Executive Vice President |
303,151 |
2026-03-05 |
|
| 4 |
Boshoff Christoffel |
President, R&d |
259,844 |
2026-03-05 |
|
| 5 |
Denton David M |
Chief Financial Officer & EVP |
216,537 |
2026-03-05 |
|
| 6 |
Malik Aamir |
Executive Vice President |
194,883 |
2026-03-05 |
|
| 7 |
Lankler Douglas M |
Executive Vice President |
194,883 |
2026-03-05 |
|
| 8 |
De Germay Alexandre |
Executive Vice President |
194,883 |
2026-03-05 |
|
| 9 |
Narayen Shantanu |
Director |
187,925 |
2026-03-30 |
|
| 10 |
Smith James C |
Director |
170,425 |
2026-03-30 |
|
| 11 |
Susman Sally |
Executive Vice President |
156,992 |
2025-03-06 |
|
| 12 |
Echevarria Joseph |
Director |
153,398 |
2026-03-30 |
|
| 13 |
Mcdermott Michael |
Executive Vice President |
151,576 |
2026-03-05 |
|
| 14 |
Hobbs Helen |
Director |
113,061 |
2024-04-26 |
|
| 15 |
Damelio Frank A |
Executive Vice President |
111,516 |
2022-02-25 |
|
| 16 |
Nora Johnson Suzanne M |
Director |
109,296 |
2025-04-28 |
|
| 17 |
Sahni Payal |
Executive Vice President |
108,268 |
2026-03-05 |
|
| 18 |
Pao William |
Executive Vice President |
97,765 |
2023-04-03 |
|
| 19 |
Mackenzie Alexander R |
Executive Vice President |
87,280 |
2021-12-06 |
|
| 20 |
Fonseca Lidia |
Executive Vice President |
82,284 |
2026-03-05 |
|
近期交易 (过去12个月)
| 日期 |
姓名 |
职位 |
类型 |
股数 |
股价 |
总价值 |
| 2026-03-31 |
Bourla Albert |
Chairman & CEO |
限制性股票授予 (RSU) |
21 |
- |
- |
| 2026-03-27 |
Buckley Mortimer J |
Director |
限制性股票授予 (RSU) |
1,387 |
- |
- |
| 2026-03-27 |
Echevarria Joseph |
Director |
限制性股票授予 (RSU) |
1,710 |
- |
- |
| 2026-03-27 |
Smith James C |
Director |
限制性股票授予 (RSU) |
1,664 |
- |
- |
| 2026-03-27 |
Quincey James |
Director |
限制性股票授予 (RSU) |
1,433 |
- |
- |
| 2026-03-27 |
Taraporevala Cyrus |
Director |
限制性股票授予 (RSU) |
1,387 |
- |
- |
| 2026-03-27 |
Narayen Shantanu |
Director |
限制性股票授予 (RSU) |
1,849 |
- |
- |
| 2026-03-13 |
Bourla Albert |
Chairman & CEO |
限制性股票授予 (RSU) |
1,630 |
- |
- |
| 2026-03-03 |
Baum Andrew |
Executive Vice President |
限制性股票授予 (RSU) |
303,151 |
$26.58 |
$8.06M |
| 2026-03-03 |
De Germay Alexandre |
Executive Vice President |
限制性股票授予 (RSU) |
194,883 |
$26.58 |
$5.18M |
| 2026-03-03 |
Boshoff Christoffel |
President, R&d |
限制性股票授予 (RSU) |
259,844 |
$26.58 |
$6.91M |
| 2026-03-03 |
Mcdermott Michael |
Executive Vice President |
限制性股票授予 (RSU) |
151,576 |
$26.58 |
$4.03M |
| 2026-03-03 |
Malik Aamir |
Executive Vice President |
限制性股票授予 (RSU) |
194,883 |
$26.58 |
$5.18M |
| 2026-03-03 |
Sahni Payal |
Executive Vice President |
限制性股票授予 (RSU) |
108,268 |
$26.58 |
$2.88M |
| 2026-03-04 |
Damico Jennifer B. |
SVP & Controller |
RSU 预扣税 |
826 |
$26.62 |
$21.99K |
| 2026-03-03 |
Damico Jennifer B. |
SVP & Controller |
限制性股票授予 (RSU) |
22,638 |
$26.58 |
$601.72K |
| 2026-03-03 |
Bourla Albert |
Chairman & CEO |
限制性股票授予 (RSU) |
708,666 |
$26.58 |
$18.84M |
| 2026-03-03 |
Lankler Douglas M |
Executive Vice President |
限制性股票授予 (RSU) |
194,883 |
$26.58 |
$5.18M |
| 2026-03-03 |
Fonseca Lidia |
Executive Vice President |
限制性股票授予 (RSU) |
82,284 |
$26.58 |
$2.19M |
| 2026-03-03 |
Denton David M |
Chief Financial Officer & EVP |
限制性股票授予 (RSU) |
216,537 |
$26.58 |
$5.76M |
| 2026-02-27 |
Damico Jennifer B. |
SVP & Controller |
RSU 预扣税 |
655 |
$27.65 |
$18.11K |
| 2026-02-25 |
Boshoff Christoffel |
President, R&d |
RSU 预扣税 |
6,833 |
$27.09 |
$185.11K |
| 2026-02-26 |
Mcdermott Michael |
Executive Vice President |
RSU 预扣税 |
3,503 |
$27.10 |
$94.93K |
| 2026-02-25 |
Mcdermott Michael |
Executive Vice President |
期权行权（卖出） |
37,925 |
$33.82 |
$1.28M |
| 2026-02-25 |
Sahni Payal |
Executive Vice President |
期权行权（卖出） |
56,888 |
$33.82 |
$1.92M |
